(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RYALTRIS (OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE)

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

RYALTRIS (OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE)

ST13

US500000097523305

Class

5

Filing

97523305

Registration

7306494

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

05/24/2025

Trademark type

Combined

Nice classes

5

Filing date

07/07/2022

Registration date

02/13/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/13/2024

Last transaction

05/24/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

08/18/2022

First use in commerce

08/18/2022

Drawing code

3

Owner type

99

Owner location

La Chaux-De-Fonds, CH

Examiner

WUDARSKY, MINDY

Law office

M80

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a three-dimensional trade dress packaging carton for the goods, in which the front and left side panels feature colored overlapping arches, colored purple (Pantone code PMS 682), light blue (Pantone code PMS 311) and light green (Pantone code PMS 374), the colors are fading toward the wide parts of the arches. The front panel and back panel feature the stylized word "RYALTRIS" in purple above the words "(OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE)" in black. This wording appears in the upper portion of the front and back panels, right to the light blue arch. The back panel of carton features the same colored arches, but they are wider at the place of overlap and only part of the light blue arch slightly overruns on the right panel on one side and parts of the light blue and light green arches from the front panel appear a little on the other side, at the bottom, whereas most of the right panel does not feature any elements of the trade dress. The backgrounds of the panels are white. The matter shown by the broken or dotted lines is not a part of the mark and serves only to show the position of the mark.

Holders and representatives

Holders

Glenmark Specialty S.A.
Glenmark Specialty S.A.

Representatives

Maxim A. Voltchenko KAPLAN BREYER SCHWARZ, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Antihistaminenasal steroidnasal spray product for treatment of respiratory disorder; Antihistamine delivery device sold filled; nasal steroid delivery device sold filled

Publications

History of USPTO decisions and trademark events.

30 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/19/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

05/19/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/19/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/19/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/19/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/19/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/13/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

02/13/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/09/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/08/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/05/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/04/2024

IUAF

USE AMENDMENT FILED

12/13/2023

EISU

TEAS STATEMENT OF USE RECEIVED

12/13/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/17/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/22/2023

PUBO

PUBLISHED FOR OPPOSITION

08/22/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/02/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/20/2023

PCGR

PETITION TO DIRECTOR GRANTED

07/18/2023

APET

ASSIGNED TO PETITION STAFF

06/12/2023

DOCK

ASSIGNED TO EXAMINER

05/12/2023

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

08/25/2022

CFDD

REQUEST TO CORRECT FILING DATE DENIED

08/24/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/24/2022

APET

ASSIGNED TO PETITION STAFF

08/22/2022

PCRC

PETITION TO DIRECTOR RECEIVED

08/08/2022

TPDR

TEAS PETITION TO DIRECTOR RECEIVED

08/08/2022

ERCF

TEAS REQUEST TO CHANGE FILING DATE.

08/08/2022

NWAP

NEW APPLICATION ENTERED

07/30/2022

Continuous trademark protection

Get notified about every new filing that threatens RYALTRIS (OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE) or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.